Craft

Merck

Stock Price

$130.7

2024-04-25

Market Capitalization

$318.6 B

2024-04-20

Revenue

$60.1 B

FY, 2023

Merck Summary

Company Summary

Overview
Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals. The company operates through two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment includes human health pharmaceutical and vaccine products that consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies, and managed health care providers. The Animal Health segment discovers, develops, manufactures, and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment, and control of disease in major livestock and companion animal species.
Type
Public
Status
Active
Founded
1891
HQ
Rahway, NJ, US | view all locations
Website
https://www.merck.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Robert M. Davis

    Robert M. Davis, Chairman and Chief Executive Officer

  • Sanat Chattopadhyay

    Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division

  • Richard R. DeLuca, Jr.

    Richard R. DeLuca, Jr., Executive Vice President and President, Merck Animal Health

  • Dean Y. Li

    Dean Y. Li, Executive Vice President and President, Merck Research Laboratories

Operating MetricsView all

Patent Portfolios

22
12.0%

FY, 2022

Phase III Drug Candidate

9
12.5%

FY, 2022

Phase III Trials Products

32
14.3%

FY, 2022

LocationsView all

224 locations detected

  • Rahway, NJ HQ

    United States

    126 E Lincoln Ave

  • Alpharetta, GA

    United States

    11605 Haynes Bridge Rd #300

  • Boston, MA

    United States

    33 Avenue Louis Pasteur

  • Branchburg, NJ

    United States

    3070 US-22

  • Durham, NC

    United States

    5325 Old Oxford Rd

  • Elkton, VA

    United States

    2778 S E Side Hwy

and 218 others

Merck Financials

Summary Financials

Revenue (FY, 2023)
$60.1B
Gross profit (FY, 2023)
$44.0B
Net income (FY, 2023)
$365.0M
Cash (FY, 2023)
$6.8B
Enterprise value
$346.8B

Footer menu